Authors: Rabizadeh, E Bairey, O Aviram, A Ben-Dror, I Shaklai, M Zimra, Y

Citation: E. Rabizadeh et al., Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient, EUR J HAEMA, 66(4), 2001, pp. 263-271

Authors: Bairey, O Zimra, Y Shaklai, M Rabizadeh, E

Citation: O. Bairey et al., Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia, BR J HAEM, 113(2), 2001, pp. 400-406

Authors: Bairey, O Zimra, Y Kaganovsky, E Shaklai, M Okon, E Rabizadeh, E

Citation: O. Bairey et al., Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas, MED ONCOL, 17(4), 2000, pp. 314-318

Authors: Aviram, A Rabizadeh, E Zimra, Y Yeshoron, M Marmelstein, M Shaklai, M Bairey, O

Citation: A. Aviram et al., Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease, EUR J HAEMA, 64(2), 2000, pp. 80-84

Authors: Zimra, Y Nudelman, A Zhuk, R Rabizadeh, E Shaklai, M Aviram, A Rephaeli, A

Citation: Y. Zimra et al., Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis, J CANC RES, 126(12), 2000, pp. 693-698

Authors: Bairey, O Zimra, Y Shaklai, M Okon, E Rabizadeh, E

Citation: O. Bairey et al., Bcl-2, Bcl-X, Pax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas, CLIN CANC R, 5(10), 1999, pp. 2860-2866